Clinical Trial Update: Gemcitabine and Docetaxel With or Without Bevacizumab (Onbevzi) for Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating gemcitabine and docetaxel with or without bevacizumab (Onbevzi) for soft tissue sarcoma; the study is currently not rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Gemcitabine (Gemcitabine)
• Onbevzi (bevacizumab)

Snippet

Sponsor: Yonsei University | Conditions: Neoplasms of Connective and Soft Tissue With an Unspecified Anatomical Site | Phase 2 | Status: NOT_YET_RECRUITING